Donadores de óxido nítrico como hipotensores en glaucoma

Archivos de la Sociedad Española de Oftalmología - Tập 93 - Trang 290-299 - 2018
V. Andrés-Guerrero1, J. García-Feijoo1,2
1Servicio de Oftalmología, Instituto de Investigación Sanitaria San Carlos (IdISSC), Hospital Clínico San Carlos. Red de Enfermedades Oculares OftaRed, Instituto de Salud Carlos III, Madrid, España
2Departamento de Oftalmología y ORL, Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España

Tài liệu tham khảo

Quigley, 1996, Number of people with glaucoma worldwide, Br J Ophthalmol., 80, 389, 10.1136/bjo.80.5.389

Tham, 2014, Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis, Ophthalmology., 121, 2081, 10.1016/j.ophtha.2014.05.013

European Glaucoma Society. Terminology and Guidelines for Glaucoma. 4th ed. EGS, editor. Italy: PubliComm; 2014. 197 pp.

Lütjen-Drecoll, 2005, Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease, Exp Eye Res., 81, 1, 10.1016/j.exer.2005.02.008

Andrés-Guerrero, 2017, Targeting Schlemm's canal in the medical therapy of glaucoma: Current and future considerations, Adv Ther., 34, 1049, 10.1007/s12325-017-0513-z

Bogdan, 2001, Nitric oxide and the immune response, Nat Immunol., 2, 907, 10.1038/ni1001-907

Moncada, 1991, Nitric oxide: Physiology, pathophysiology, and pharmacology, Pharmacol Rev., 43, 109

Aktan, 2004, iNOS-mediated nitric oxide production and its regulation, Life Sci, 75, 639, 10.1016/j.lfs.2003.10.042

Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly, Am J Physiol., 271, C1424, 10.1152/ajpcell.1996.271.5.C1424

Murphy, 2003, Re-establishment of neurochemical coding of preganglionic neurons innervating transplanted targets, Neuroscience., 117, 347, 10.1016/S0306-4522(02)00828-X

Tayfun Uzbay, 2001, Nitric oxide and substance dependence, Neurosci Biobehav Rev., 25, 43, 10.1016/S0149-7634(00)00049-X

Mariotto, 2004, Biochemical aspects of nitric oxide, Curr Pharm Des., 10, 1627, 10.2174/1381612043384637

Lundberg, 2008, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics, Nat Rev Drug Discov., 7, 156, 10.1038/nrd2466

Lundberg, 2010, NO-synthase independent NO generation in mammals, Biochem Biophys Res Commun., 396, 39, 10.1016/j.bbrc.2010.02.136

Kone, 2003, Protein interactions with nitric oxide synthases: Controlling the right time, the right place, and the right amount of nitric oxide, Am J Physiol Renal Physiol., 285, F178, 10.1152/ajprenal.00048.2003

Krumenacker, 2004, Regulation of nitric oxide and soluble guanylyl cyclase, Brain Res Bull., 62, 505, 10.1016/S0361-9230(03)00102-3

Bishop, 2005, NO signaling in the CNS: From the physiological to the pathological, Toxicology., 208, 193, 10.1016/j.tox.2004.11.034

Anggård, 1994, Nitric oxide: Mediator, murderer, and medicine, Lancet., 343, 1199, 10.1016/S0140-6736(94)92405-8

Doganay, 2002, Decreased nitric oxide production in primary open-angle glaucoma, Eur J Ophthalmol., 12, 44, 10.1177/112067210201200109

Cavet, 2014, Nitric oxide (NO): An emerging target for the treatment of glaucoma, Invest Opthalmol Vis Sci., 55, 5005, 10.1167/iovs.14-14515

Kroll, 1998, VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR), Biochem Biophys Res Commun., 252, 743, 10.1006/bbrc.1998.9719

Chang, 2015, Role of nitric oxide in murine conventional outflow physiology, Am J Physiol Cell Physiol., 309, C205, 10.1152/ajpcell.00347.2014

Nathanson, 1995, Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye, Invest Ophthalmol Vis Sci., 36, 1765

Kang, 2010, Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: Interactions with sex and postmenopausal hormone use, Invest Ophthalmol Vis Sci., 51, 971, 10.1167/iovs.09-4266

Fukumura, 2001, Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability, Proc Natl Acad Sci U S A., 98, 2604, 10.1073/pnas.041359198

Dismuke, 2008, NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel, Am J Physiol Cell Physiol., 294, C1378, 10.1152/ajpcell.00363.2007

Ellis, 2009, Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork, Invest Ophthalmol Vis Sci., 50, 1808, 10.1167/iovs.08-2750

Last, 2011, Elastic modulus determination of normal and glaucomatous human trabecular meshwork, Invest Ophthalmol Vis Sci., 52, 2147, 10.1167/iovs.10-6342

Ashpole, 2014, Shear stress-triggered nitric oxide release from Schlemm's canal cells, Invest Ophthalmol Vis Sci., 55, 8067, 10.1167/iovs.14-14722

Wiederholt, 1994, Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide, Invest Ophthalmol Vis Sci., 35, 2515

Schneemann, 2002, Nitric oxide/guanylate cyclase pathways and flow in anterior segment perfusion, Graefes Arch Clin Exp Ophthalmol., 240, 936, 10.1007/s00417-002-0559-7

Ellis, 2010, Endogenous regulation of human Schlemm's canal cell volume by nitric oxide signaling, Invest Ophthalmol Vis Sci., 51, 5817, 10.1167/iovs.09-5072

Stamer, 2011, eNOS, a pressure-dependent regulator of intraocular pressure, Invest Ophthalmol Vis Sci., 52, 9438, 10.1167/iovs.11-7839

Nathanson, 1995, Alterations of ocular nitric oxide synthase in human glaucoma, Invest Ophthalmol Vis Sci., 36, 1774

Kang, 2011, Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: Interactions with hypertension, alcohol intake, and cigarette smoking, Arch Ophthalmol., 129, 773, 10.1001/archophthalmol.2011.118

Magalhães da Silva, 2012, Association of polymorphisms of endothelial nitric oxide synthase (eNOS) gene with the risk of primary open angle glaucoma in a Brazilian population, Gene., 502, 142, 10.1016/j.gene.2012.04.047

Weiss, 2012, No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients, Mol Vis., 18, 2174

Coubrough, 1985, Stress and fertility. A review, Onderstepoort J Vet Res., 52, 153

Funk, 1996, Short-term hemodynamic changes in episcleral arteriovenous anastomoses correlate with venous pressure and IOP changes in the albino rabbit, Curr Eye Res., 15, 87, 10.3109/02713689609017615

Gabelt, 2011, Effect of nitric oxide compounds on monkey ciliary muscle in vitro, Exp Eye Res., 93, 321, 10.1016/j.exer.2010.12.003

Shahidullah, 2005, Cyclic GMP sodium nitroprusside and sodium azide reduce aqueous humour formation in the isolated arterially perfused pig eye, Br J Pharmacol., 145, 84, 10.1038/sj.bjp.0706156

Millar, 2001, Intraocular pressure and vascular effects of sodium azide in bovine perfused eye, J Ocul Pharmacol Ther., 17, 225, 10.1089/108076801750295263

Miller, 2001, Description of ciliary body anatomy and identification of sites for transscleral cyclophotocoagulation in the equine eye, Vet Ophthalmol., 4, 183, 10.1046/j.1463-5216.2001.00147.x

Fleischhauer, 2000, NO/cGMP pathway activation and membrane potential depolarization in pig ciliary epithelium, Invest Ophthalmol Vis Sci., 41, 1759

Wu, 2004, Role of anions in nitric oxide-induced short-circuit current increase in isolated porcine ciliary processes, Invest Ophthalmol Vis Sci., 45, 3213, 10.1167/iovs.03-1252

Neufeld, 1997, Nitric oxide synthase in the human glaucomatous optic nerve head, Arch Ophthalmol., 115, 497, 10.1001/archopht.1997.01100150499009

Kim, 2002, A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma, Invest Ophthalmol Vis Sci., 2192

Pang, 2005, Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage, Invest Ophthalmol Vis Sci, 46, 1313, 10.1167/iovs.04-0829

Libby, 2007, Inducible nitric oxide synthase Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model, BMC Neurosci., 8, 108, 10.1186/1471-2202-8-108

Chen, 2013, Altered expression of nNOS/NIDD in the retina of a glaucoma model of DBA/2J mice and the intervention by nNOS inhibition, J Mol Neurosci., 51, 47, 10.1007/s12031-012-9943-x

Toda, 2007, Nitric oxide: Ocular blood flow, glaucoma, and diabetic retinopathy, Prog Retin Eye Res., 26, 205, 10.1016/j.preteyeres.2007.01.004

Flammer, 1998, Optic nerve blood-flow abnormalities in glaucoma, Prog Retin Eye Res., 17, 267, 10.1016/S1350-9462(97)00006-2

Hashitani, 1998, Neuroeffector transmission in arterioles of the guinea-pig choroid, J Physiol., 510, 209, 10.1111/j.1469-7793.1998.209bz.x

Yamamoto, 1993, The localization of nitric oxide synthase in the rat eye and related cranial ganglia, Neuroscience., 54, 189, 10.1016/0306-4522(93)90393-T

Chen, 1998, Histochemical mapping of NADPH-diaphorase in monkey and human eyes, Curr Eye Res., 17, 370, 10.1080/02713689808951217

Haefliger, 1992, Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery, Invest Ophthalmol Vis Sci, 33, 3

Yao, 1991, Endothelium-dependent regulation of vascular tone of the porcine ophthalmic artery, Invest Ophthalmol Vis Sci, 32, 8

Deussen, 1993, L-arginine-derived nitric oxide: A major determinant of uveal blood flow, Exp Eye Res., 57, 129, 10.1006/exer.1993.1107

Granstam, 1998, Endothelium-dependent vasodilation in the uvea of hypertensive and normotensive rats, Curr Eye Res., 17, 189, 10.1076/ceyr.17.2.189.5609

Seligsohn, 1993, Effects of NG-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone, Br J Pharmacol., 109, 1219, 10.1111/j.1476-5381.1993.tb13752.x

Jacot, 1998, Nitric oxide modulation of retinal, choroidal, and anterior uveal blood flow in newborn piglets, J Ocul Pharmacol Ther., 14, 473, 10.1089/jop.1998.14.473

Dorner, 2003, Nitric oxide regulates retinal vascular tone in humans, Am J Physiol Heart Circ Physiol., 285, H631, 10.1152/ajpheart.00111.2003

Polak, 2007, Altered nitric oxide system in patients with open-angle glaucoma, Arch Ophthalmol., 125, 494, 10.1001/archopht.125.4.494

Kanno, 2000, Effects of topical nipradilol, a beta blocking agent with alpha blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans, Br J Ophthalmol., 84, 293, 10.1136/bjo.84.3.293

Kida, 2001, The effect of nipradilol, an alpha-beta blocker, on retinal blood flow in healthy volunteers, Curr Eye Res., 23, 128, 10.1076/ceyr.23.2.128.5475

Mizuno, 2002, Topical nipradilol: Effects on optic nerve head circulation in humans and periocular distribution in monkeys, Invest Ophthalmol Vis Sci., 43, 3243

Kaufman, 2017, Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension, Expert Opin Pharmacother., 18, 433, 10.1080/14656566.2017.1293654

Krauss, 2011, Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models, Exp Eye Res., 93, 250, 10.1016/j.exer.2011.03.001

Araie, 2015, Evaluation of the effect of latanoprostene bunod ophthalmic solution, 0.024% in lowering intraocular pressure over 24 h in healthy Japanese subjects, Adv Ther., 32, 1128, 10.1007/s12325-015-0260-y

Weinreb, 2015, A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: The VOYAGER study, Br J Ophthalmol., 99, 738, 10.1136/bjophthalmol-2014-305908

Liu, 2016, Efficacy of latanoprostene bunod 0.024% compared with timolol 0.5% in lowering intraocular pressure over 24 hours, Am J Ophthalmol., 169, 249, 10.1016/j.ajo.2016.04.019

Weinreb, 2016, Latanoprostene bunod 0.024% versus timolol maleate 0.5% in subjects with open-angle glaucoma or ocular hypertension: The APOLLO study, Ophthalmology., 123, 965, 10.1016/j.ophtha.2016.01.019

Medeiros, 2016, Comparison of latanoprostene bunod 0.024% and timolol maleate 0.5% in open-angle glaucoma or ocular hypertension: The LUNAR study, Am J Ophthalmol., 168, 250, 10.1016/j.ajo.2016.05.012

Thông tin
Thông tin xuất bản

Archivos de la Sociedad Española de Oftalmología

Tập 93

290-299

Thông tin tác giả